Loss from operations (54,747) (94,423) (230,546) (316,952)
Change in fair
value of
derivative tranche
liability - - - 10,291
Interest income 7,535 10,502 25,132 20,486
Other income
(expense), net (1,336) (19) 36,221 (254)
Net loss $ (48,548) $ (83,940) $ (169,193) $ (286,429)
---------- ---------- ---------- ----------
Other comprehensive
gain (loss)
Unrealized gain
(loss) on
short-term
marketable
securities, net 551 (94) 222 36
Total other
comprehensive
gain (loss) $ 551 $ (94) $ 222 $ 36
---------- ---------- ---------- ----------
Net loss and other
comprehensive loss $ (47,997) $ (84,034) $ (168,971) $ (286,393)
========== ========== ========== ==========
Net loss per share
attributable to
common
stockholders, basic
and diluted $ (0.49) $ (0.87) $ (1.71) $ (4.68)
Weighted-average
common shares
outstanding, basic
and diluted 99,835,707 96,872,747 98,973,518 61,138,105
========== ========== ========== ==========
ACELYRIN, INC.
Selected Consolidated Balance Sheet Data
(unaudited)
(in thousands)
September 30, December 31,
------------------------ ------------------------
2024 2023
---------------- ----------------
Cash and cash
equivalents $ 216,326 $ 218,097
Short-term
marketable
securities 346,047 503,229
Total assets 618,310 742,690
Total liabilities 90,029 86,353
Accumulated deficit (657,912) (488,719)
ACELYRIN Contacts:
Tyler Marciniak
Vice President of Investor Relations and Corporate Affairs
investors@acelyrin.com
media@acelyrin.com
(END) Dow Jones Newswires
November 13, 2024 16:00 ET (21:00 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.